Latest News
Mid-market private equity firm CBPE Capital has sold Rosemont Pharmaceuticals to Perrigo, the USD10bn US listed pharmaceuticals business.
CBPE acquired Rosemont in August 2006 for GBP93m. The sale to Perrigo represents an investment multiple of 3.25x CBPE’s GBP52m equity investment over the investment period for CBPE’s investors.
Rosemont develops, manufactures and supplies oral liquid medicines for patients who have difficulty in swallowing tablets and capsules. Its customers include hospitals, wholesalers and retail pharmacies. Rosemont’s range of medicines improves the lives of patients with swallowing difficulties which typically affect the elderly and young children.
CBPE has funded significant investment
It is much harder for countries to make the transition from emerging to developed economies than was previously commonly thought, according to Frances Hudson (pictured), Global Thematic Strategist, Standard Life Investments…
Evidence suggests that it is much harder for countries to make the transition from emerging to developed economies than is commonly thought. According to the World Bank, only 13 countries have moved from upper middle to high income – one of the measures of a developed economy – since 1960. Of those, five are the Asian tigers; others include Greece, Ireland, Spain and Israel.
In considering the investment potential
Private equity firm Hellman & Friedman has promoted Hunter Philbrick, Judd Sher and Tarim Wasim to managing directors.
Philbrick (pictured) joined Hellman & Friedman in 2003 in the firm’s San Francisco office and relocated to New York in 2005 to help build the New York office. He primarily focuses on healthcare and insurance investments and currently serves on the boards of Pharmaceutical Product Development and Sedgwick.
Sher joined Hellman & Friedman last year as chief financial officer. He brings over 13 years of experience, most recently as a principal in Deloitte’s M&A transaction services group, and is responsible for all
Cleantech investment specialist MTI Partners has completed a GBP2m investment round in Oxford Photovoltaics (OPV), an Oxford University spin-out materials/cleantech company commercialising solid-state dye sensitized solar cells for the building integrated photovoltaic (BIPV) sector.
These new, transparent solar cells can be produced from inexpensive, abundant, non-toxic and non-corrosive materials and be scaled to any volume. They can be printed directly onto glass in a range of colours, making them ideally suited to use in glazing panels and facades.
This latest investment round allows OPV to build on its technical and commercial teams and construct its own product development and test
AziNam, the offshore Namibia focused exploration company, has opened an office in Dubai’s Multi Commodities Center in the JLT Free Zone in the United Arab Emirates, having established itself as one of the largest gross acreage holders offshore Namibia.
The company, backed by the Bermuda-based energy investment group Seacrest Capital, holds interests in six licences covering c. 67,000km2, across the Walvis and Luderitz basins.
A combination of heightened industry interest in the country coupled with recent licensing and exploration success in geologically analogous regions, including the Falkland Islands, Uruguay and Angola, has made the region one of the most
Despite a decade of significant industry contraction and recent fundraising and liquidity challenges, many VC firms remain optimistic for 2013, according to the inaugural Venture Capital Outlook report from Rothstein Kass.
The survey of 117 VC firms titled “Venture Capital – Renewed Optimism: But Have We Turned the Corner” reveals that for the majority of firms the optimism is driven by the belief that the Jumpstart Our Business Startups (JOBS) Act will provide access to new capital and exit opportunities.
The survey is the latest initiative designed to provide insights and information to the financial services and alternative investment segments
DW Healthcare Partners, a healthcare-focused private equity firm, has completed fundraising for its third fund, DWHP III, which has closed with USD265m of committed capital, exceeding its original target of USD250m.
DWHP III investors are comprised of pension plans, foundations, fund of funds, high net-worth individuals and family trusts.
Andrew Carragher, DWHP co-founder and managing director, says: "Through our partnerships with talented founders and management teams in our portfolio companies, we have been able to sustain a consistent track record of delivering above-average returns to our investors. As a result, we attracted a great deal of interest while fundraising for
Salvepar, an investment company which is 92 per cent owned by the Tikehau Group, has sold three of its holdings.
Salvepar conducts an active policy of minority and medium-term shareholding acquisitions in listed and non-listed companies.
The firm has accepted a firm and binding offer for its entire shareholding in Polygone SA from its co-founder Olivier Ginon for a total amount of EUR9.2m.
As a result of Qualium Investissement’s sale of its shareholding in Socotec to Cobepa (a Belgian investment company) and to funds managed by Five Arrows Managers, as well as to the management and employees, Salvepar’s mezzanine bonds
EQT IV has signed an agreement with an affiliate of Sun European Partners, the European adviser to Sun Capital Partners, to sell BTX Group.
BTX is a wholesaler comprised of five brands: Brandtex, Jensen Women, Signature, Imitz and Ciso, all of which have their own identity, addressing various sub-segments of the mature womenswear market.
During EQT IV’s ownership period, BTX has been through a significant transformation. Being initially a traditional manufacturing and wholesale company, the company is today a focused clothing business, targeting the classic mature woman and having a clear retail-focus, including more than 120 shop-in-shops solutions with its
The London office of international legal practice Norton Rose has advised UBM on the proposed GBP160m disposal of certain parts of its data services business to Electra Private Equity Partners.
UBM’s proposed disposal of its data services business consists of five divisions: Aviation, Global Trade, Medica, RISI and Tech Insights.
The disposal involves the sale of 70 companies in 44 jurisdictions and asset sales in the UK, China, Hong Kong, Singapore and Japan.
As well as London, the transaction involved additional advice being sought from 15 Norton Rose offices globally, in Australia, Canada, China, France, Germany, Holland, Hong Kong, Japan,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
